Resources

Ceci est un guide des médicaments recommandés pour la gestion des conditions courantes au Kenya.

Over the past 15 years, PATH has worked in low-and middle-income countries, including Ghana, Peru, Rwanda, and Ukraine, to evaluate and strengthen breast cancer early detection, diagnosis, treatment, and recovery. We use our technical capacity, country presence, and extensive global and in-country networks to pursue culturally appropriate programmatic and technological innovations to extend survival and improve quality of life for women diagnosed with breast cancer.

PATH conducted a health systems assessment exploring opportunities and challenges related to the potential future introduction of the SILCS diaphragm in India. An opportunity to expand women’s options for contraceptive protection, this nonhormonal method could address the unmet reproductive health needs of many women in India.

PATH and the US government work together to save lives and improve health in developing countries, especially for women and children. These educational fact sheets help policymakers understand the breadth of US government support for programs focused on ending preventable maternal and child deaths, improving global immunization, and fostering global health research and development, while also highlighting the impact and potential of global health innovations through PATH examples.

PATH, in collaboration with the Epidemiology & Disease Control Division, Government of Nepal, and B.P. Koirala Institute of Health Sciences, Dharan, is implementing a focused pharmacovigilance program for kala-azar, or visceral leishmaniasis (VL), in Nepal. The program aims to strengthen patient safety and care associated with the use of VL drugs. The results of the pharmacovigilance activities are summarized in this newsletter.